1. Division of Hematology, Oncology and Stem Cell Transplantation, Medical Clinic I, Department of Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany;
2. National Center for Tumor Diseases, Dresden, Germany;
3. Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany;
4. GEMoaB GmbH, Dresden, Germany;
5. Comprehensive Cancer Center Mainfranken, Early Clinical Trials Unit, University Hospital Würzburg, Würzburg, Germany; and
6. Cellex Manufacturing Transports and Logistics GmbH, Cologne, Germany